Brief: Onward Medical Says Arc-Ex Therapy Study Achieved All Primary Safety & Effectiveness Endpoints
20/05/2024 16:38
May 20 (Reuters) - Onward Medical NV ONWD.BR :
* : STUDY ACHIEVED ALL PRIMARY SAFETY & EFFECTIVENESS
ENDPOINTS, &
ARC-EX THERAPY DEMONSTRATED SIGNIFICANT IMPROVEMENTS
* PLANS TO FOLLOW US APPLICATION WITH AN APPLICATION FOR
MARKET
APPROVAL IN EUROPE.
Source text for Eikon: ID:nGNE1ppZbf
Further company coverage: ONWD.BR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ONWARD Medical
See all newsBrief: Onward Medical Primary ABB Final Deal Size Was C.Eur 50m / 11.3m Shares, Says Bookrunner
Brief: Ottobock Invests EUR 10 Million In Onward Medical
Brief: Bookrunner Says Onward Medical Primary ABB Books Covered, Further Guidance To Follow
Brief: ONWARD Medical Receives FDA De Novo Classification
Brief: Onward Medical Says Receives FDA De Novo Classification And US Market Authorization For ARC-EX System